At Emerald Development Managers, we not only provide long-term investment capital, we also guide our early-stage companies along a strategic path to profitability, increased market share, and sustained growth. Here's how some of our current portfolio companies are doing.
Rockwell Automation, Inc., the world’s largest company dedicated to industrial automation and digital transformation, announced today a strategic investment in READY Robotics, a pioneering company in software-defined automation and a Rockwell Technology Partner.
Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia® – a leader in digital pathology – to offer a comprehensive digital diagnostic pathology system.
HPE intends to acquire Axis Security, a cloud security provider, expanding its edge-to-cloud security capabilities by offering a unified Secure Access Services Edge (SASE) solution to meet the increasing demand for integrated networking and security solutions delivered as-a-service.
Transcend Therapeutics Inc. raised $40 million from venture-capital investors in January to develop a post-traumatic stress disorder treatment that its 29-year-old CEO Blake Mandell says would require about half the amount of therapy as MDMA, or ecstasy, a popular hallucinogen.
WATT Fuel Cell is excited to announce an investment from Generac Power Systems, a market leader in residential energy technology.
Emerald Development Managers, an early-stage venture capital firm, today announced that Ian Tolfree, Ph.D., and Cy Schroeder have been named Principals of the firm and Joshua Smith has been promoted to Director, Investor Relations.
Capital Rx, a healthcare technology company changing the way prescription drugs are priced and patients are serviced, today announced that it has won the Fierce Healthcare Fierce Innovation Award. The healthcare awards program recognized Capital Rx for JUDI®, its ground-breaking enterprise health platform (EHP) for pharmacy benefit administration.
Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, today announced it has closed its $13 million Series A1 round led by Werth Family Investment Associates, LLC and Connecticut Innovations, Inc., bringing the total raised by the company to $18 million.
GreenSight’s WeaterHive, a unique new sensing technology that uses swarms of nano-sized drones to directly measure atmospheric conditions, has been selected by the US Air Force and the Defense Innovation Unit for a prototype development contract and potential procurement.
LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced positive six-month interim results from its pivotal clinical trial of Lumina™, a revolutionary dermal filler.
Proscia, a leading provider of digital and computational pathology solutions, has introduced the next version of its Concentriq® Dx platform for primary diagnostic workflows. The release brings together new features and a compelling user experience to help even the largest laboratory networks transition to 100% digital diagnosis.
Evolved by Nature has raised $120 million in Series C financing in a round led by Teachers’ Venture Growth, part of the Ontario Teachers’ Pension Plan Board, and Senator Investment Group, with participation from existing investors including Mousse Partners, Jeff Vinik, The Kraft Group, Roy Disney, Emerald Development Managers and Chanel.
With $37 million in new funding, Philadelphia-based Proscia is using computational pathology to advance the ways in which cancer is understood and treated.
Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, announced today that it has entered into a national distribution agreement with MWI Animal Health, a leading distributor of animal health products and services and a subsidiary of AmerisourceBergen. The agreement will expand access to Torigen’s experimental autologous cancer vaccine for companion animals.
Emerald Development Managers today announced that Abbe Serphos has been appointed Operating Partner and Head of Communications for the firm.
On Monday, New York-based Capital Rx announced it has raised $106 million in Series C funding led by B Capital Group, which brings the company’s total funding to $175 million since launching in 2017. General Catalyst, Transformation Capital and Edison Partners also participated in the round. The company declined to disclose its post-money valuation.
WATT Fuel Cell Corp ("WATT") announced their new 1500W Imperiumᴿ Solid Oxide Fuel Cell System received ETL certification to operate on either natural gas or liquid propane gas. The system's ETL certification complies to North American safety standards.
Last year, U.K. cybersecurity startup CybSafe, a “behavioral security” platform, raised a $7.9 million Series A. It’s now raised a $28 million Series B round led by Evolution Equity Partners with participation from Emerald Development Managers and existing investors IQ Capital and Hannover Digital Investments (HDI) GmbH.
READY Robotics, pioneers in software-defined automation, today announced a strategic investment from NVIDIA, the leader in accelerated computing technology.
WATT Fuel Cell ("WATT") announced a technological advancement that dramatically increases the efficiency of its fuel cells and reduces their already minimal CO2 emissions.
BD is expanding its long-running partnership with the blood collection company Babson Diagnostics, which aims to make taking a high-quality sample in pharmacies, grocery stores or at home as easy as possible.
Today, Intellihot, the leading clean technology manufacturer creating sustainable solutions for the built environment, announced its partnership with the iconic Loews Miami Beach Hotel to upgrade the hotel’s hot water systems. The innovative iQ1505 Intellihot replaced the previous legacy system of three large boilers and 1,200 gallons of stored water, which will reduce energy waste and the hotel’s carbon footprint while improving cost effectiveness.
Largest consultant led pharmacy coalition in the U.S. taps Capital Rx to offer clients flexibility, transparency, and competitive drug pricing.
Proscia®, the leader in digital and computational pathology solutions, today announced a multi-year OEM agreement with Siemens Healthineers. Under the agreement, Siemens Healthineers will expand its Enterprise Imaging offering towards the global digital pathology market using Proscia’s Concentriq® Dx platform.
WATT Fuel Cell announced today that it has closed a financing round led by EQT Corporation, the largest natural gas producer in the United States, to continue the company's development and commercialization of its solid oxide fuel cell technology.
Intellihot — a leading greentech manufacturer working to improve the sustainability of commercial buildings — released its 2022 Environmental Report outlining how its products have already reduced carbon expenditures in the built environment by 6.6 billion pounds.
Capital Rx has been chosen as one of Fierce Healthcare's 2022 "Fierce 15", a selection of the most promising healthcare companies in the industry.
Evolved By Nature, the company behind Activated Silk, has raised $70 million in funding with backers including Mousse Partners. A new production facility is to come.
Founded in 2009, Intellihot has been on a mission to make commercial buildings more efficient, by improving the cost and physical footprint of keeping building H2O nice and toasty. The company just announced it raised $50 million to shake up the $81 billion global HVAC market, with plans to expand internationally. The round was led by investors Aegon Asset Management and the Avenue Sustainable Solutions Fund.
Capital Rx, a healthtech company changing the way prescription drugs are priced and patients are serviced, was recently recognized by The Startup Weekly as a recipient of the 2021 Customer Choice Award.
SafeBreach, the pioneer in breach and attack simulation ("BAS"), today announced that it has raised $53.5 million in Series D funding, led by Sonae IM and Israel Growth Partners (IGP), with additional participation from Sands Capital and Leumi Partners.
Socure, a company that uses AI and machine learning to verify identities, announced today that it raised $450 million in funding for its Series E round led by Accel and T. Rowe Price. The round brings the company’s valuation to $4.5 billion, up from $1.3 billion this March when it raised $100 million for its Series D.
Melanoma is the deadliest form of skin cancer and can be challenging to diagnose. Earlier this month, Proscia released study data in which artificial intelligence (AI) was used to detect melanoma with a high degree of accuracy.
Proscia has released study results on new technology that leverages artificial intelligence (AI) to automatically detect melanoma, the deadliest form of skin cancer, with a high degree of accuracy.
Cyware, the industry's only Virtual Cyber Fusion platform provider, today announced that it has been named the winner of the Overall SOAR Solution Provider of the Year award in the fifth annual CyberSecurity Breakthrough Awards program conducted by CyberSecurity Breakthrough.
Cyware, the industry’s only Virtual Cyber Fusion platform provider, today announced new threat intelligence sharing abilities for industry ISACs and ISAOs and their member organizations. The capabilities are driven by Cyware’s Virtual Cyber Fusion platform and its supporting solutions that empower organizations to achieve the end-to-end threat sharing needed for collective defense.
TrueFort announces $30M Series B with participation from new firms Canaan and Ericsson Ventures along with existing investors Evolution Equity Partners, Lytical Ventures, and Emerald Development Managers.
Capital Rx announced Wednesday that it now has a consumer prescription card, Capital Rx Advantage. This card can be obtained by anyone to buy medication at a price the company says is lower 80% of the time compared to its competitors.
In the past two months, Torigen has won multiple awards at several prominent industry events including the Yale Innovation Summit and the Animal Health Innovation Showcase.
Emerald Development Managers LP leads oversubscribed $31 million Series B funding round for Babson Diagnostics with full participation from existing investors, including Siemens Healthineers.
The National Bank of Bahrain Group (NBB Group) has selected Cyware to power the first Virtual Cyber Fusion Centre (vCFC) in the region.
Proscia has introduced the next generation of its flagship Concentriq® platform to help the world’s largest laboratory networks keep pace with the growing need for diagnostic services in the post-COVID era.
Ready Robotics translates the core principles of the no-code/low-code movement from the world of web and mobile apps to the world of robotics.
Results demonstrate company’s commitment to client service, outpacing competitors.
The funding is being co-led by Advent International and Ten Eleven Ventures.
Socure — which uses AI and machine learning to verify identities — announced Tuesday that it has raised $100 million in a Series D funding round at a $1.3 billion valuation.
Due for repairs, the Grand Hyatt Vail turns to Intellihot for tankless water heating reliability, cost savings, and cutting OPEX.
The partnership assures the enhancement of secure operations and collaborative threat response in defending the space industry from both traditional and evolving cybersecurity threats.
Security Industry Luminary Brings Decades of Strategic Management and Operational Experience to New Board Seat
The funding round is led by Transformation Capital, with participation from Edison Partners, who led Capital Rx’s Series A financing in 2019, and Emerald Development Managers, LP.
Annual The Software Report List Recognizes Vendors that Provide the Most Innovative and Technically Advanced Approaches for Protecting Customers
Provider of Application and Cloud Workload Protection Cited for Innovation, Relevance and Market Adoption
Investment to accelerate adoption of digital pathology, transforming the 150-year-old standard of care for cancer diagnosis.
The multi-phase project will digitize the world’s largest human pathology specimen repository in order to enhance biomedical research for cancer and infectious diseases.